Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAMMA-SLEEP: Electrophysiological analysis of Gamma-Hydroxybutyrate-induced sleep in intensive care patients
2025-521967-11-00Phase 2Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in sleep disorder comparing Sodium oxybate arm with Placebo arm (2 arms). Primary endpoint: Duration of deep slow-wave sleep (N3 stage). Planned start Apr 2026; status: authorised.
02
Drugs
sodium oxybate
03
Conditions
sleep disorder
Beyond the preview
Go deeper on 2025-521967-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521967-11-00.